EMIM 2019
To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).
Keyword Contributions
1-[11c] acetate PS 07-04
111in-anti-mpd-l1 ab PS 07-02
13c #548PS 22-05
13c-mrs PS 13-06
165-erbium PS 08-03
18f #538
18f-dpa714 PS 23-04
18f-fdg PS 23-03
18f-labeled benzamide derivative PS 24-02
18f-naf PS 23-03
18f-naf pet/ct PS 23-04
18f[naf] PS 01-04
19f #212PS 22-05
19f mri #194PS 13-02PS 22-03PS 22-03PS 22-05PS 22-05PS 08-03PS 08-03
19f mrs PS 23-02
19f probe PS 08-03
19f-mri PS 01-01
19f/1h mri PS 08-03
1h cryocoil PS 02-03
1h nmr PS 07-04
1h-nmr PS 07-06
3-fluoro-dl-tyrosine PS 22-05
3-o-methyl-d-glucose PS 07-04
3d PS 19-06PS 07-05
3d cell culture PS 08-04
3d cones PS 22-05
3d imaging PS 16-03
3d mri-cest ph imaging PS 02-03
3d single shot PS 22-05
4d cardiac imaging PS 14-05
68-gallium radiolabeling PS 06-07
89zr labeling PS 07-02
89zr-chelates PS 23-07
[1-13c]pyruvate PS 01-03PS 13-06
[11c]ch3i PS 06-07
[11c]metoclopramide PS 13-05
[18f]az68 PS 13-05
[18f]f-dpa PS 13-04
[18f]fluorothymidine PS 24-03
[18f]naf PS 07-04
[18f]psma-1007 PS 22-04
[18f]ucb-h #520
[89zr]-desferoxamine-epo PS 23-05
[89zr]zr(oxinate)4 PS 13-05
a549 lung adeno-carcinoma cell graft PS 22-05
aazta PS 22-04PS 23-07
abc transporter #588
abcb1 induction PS 13-05
abdominal aortic aneurysm PS 24-03
absorbed dose PS 02-02
ac-225 PS 08-04
acetate PS 01-01
acetate metabolism PS 01-01
ackr3/cxcr7 PS 24-05
activatable peptide PS 24-06
activated leukocyte cell adhesion molecule (alcam) PS 13-06
active targeting PS 22-03
activity based probes PS 24-06
acute lung inflammation PS 02-04
acyclic PS 24-05
adc PS 13-06
adenosine a1 receptor PS 13-03
administration routes PS 02-02
adoptive cell transfer immunotherapy PS 07-02
adoptive t-cell therapy PS 02-04
aerosol PS 22-05
agents PS 23-02
aging PS 14-02
ai PS 07-05
al-f chelation PS 22-04
albumin PS 24-06
albumin binding PS 24-02
albumin complex PS 22-07
aldehyde dehydrogenase PS 13-04
alf-18 labeling PS 23-07
alkaptonuria PS 23-04
alpha particle irradiation #410
alpha synuclein PS 23-07
als PS 08-06
alzheimer PS 13-05
alzheimer disease PS 17-02
alzheimer's disease PS 14-02PS 23-05PS 23-05PS 23-04PS 07-07PS 07-07PS 17-02PS 17-02
amygdala circuit PS 02-05
amygdala circuits PS 07-07
amyloid PS 23-04
amyloid beta PS 13-05
amyloid-beta PS 23-05
androgen deprivation therapy PS 08-05
angiogenesis #534
angiography PS 01-03PS 14-02
animal handling PS 07-04
animal handling standardisation PS 22-05
animal model PS 07-02PS 07-04PS 08-06
animal models PS 01-07PS 14-02
anisotropic diffusion tensor PS 02-02
anthracyclines PS 01-04
anti-calcific agents PS 01-04
anti-pd1 treatment PS 07-02
antibodies PS 19-05PS 21-05PS 24-03PS 24-06
antibody #427
antibody-based multimodal imaging agent PS 08-02
anxiolytic benzodiazepine PS 02-05
apoptosis PS 13-04PS 23-07
arterial input function PS 22-05
arterial spin labeling PS 13-03
arterial tacs PS 06-07
arthoscopic PS 24-04
asl-mri PS 14-03
aspergillosis PS 01-05
astrocyte PS 14-03
astrocytes PS 08-06
atherosclerosis #271PS 01-02PS 01-04PS 01-04PS 14-04PS 07-03PS 07-03PS 23-02PS 24-03PS 24-03PS 24-03
atherosclerotic plaques PS 13-05
atm PS 21-05
atovaquone PS 22-07
atrx PS 07-04
attenuation correction PS 17-02
auger PS 14-06
automated segmentation PS 23-04
automation PS 22-04
autonomous adenomas PS 22-06
autoradiography PS 22-07
avb3 integrin #534
awake PS 07-07
aza-bodipy PS 24-06
azamacrocycle PS 24-05
b-values PS 13-06
baboon PS 01-05
bacteremia PS 01-05PS 22-03
bacteria PS 24-04
bacteria-targeted PS 24-04PS 24-04
bacterial infections PS 24-04
bbb PS 08-06
behavior evaluation PS 22-05
benchmarking PS 01-06
beta cell PS 07-04
bimodal molecular imaging PS 01-06
bimodal probe PS 23-02
bioconjugation PS 16-02
biodegradation PS 08-03
biodistribution #410PS 07-04PS 23-02PS 08-03PS 08-03PS 08-05
biofilm PS 24-04
bioinformatics PS 01-06
biomarker PS 14-06PS 07-07
biomarkers PS 21-04PS 01-07
biomaterials PS 24-04
biomedical image processing PS 23-04
biomedical imaging PS 24-06
bioorthogonal click PS 23-07
bioorthogonal labelling #430
biophysics PS 14-05
biopsy-based PS 14-03
bismuth PS 22-04
bisphosphonates PS 06-07
bli PS 23-05PS 23-05
blood PS 14-05PS 22-06
blood input function PS 23-04
blood oxygenation level dependent (bold) mri PS 22-05
blood-brain barrier PS 01-03PS 24-06PS 03-03
blood-brain-barrier PS 08-06
bnct PS 01-02PS 22-07
bodipy PS 22-07
bold PS 22-05PS 07-07
bold fmri PS 17-02PS 17-02
bold oscillations PS 17-02
bone PS 17-02
bone metastases PS 23-04
bone perfusion PS 07-04
bones PS 06-07
boron functionalizaton PS 24-06
brain #548PS 02-03PS 14-03PS 17-02
brain atrophy PS 23-05
brain connectivity PS 02-05
brain metabolism PS 23-05
brain metastases PS 02-03PS 13-06
brain metastasis PS 02-01
brain state PS 13-03
brain structure PS 08-06
brain-wide neural activation patterns PS 07-07
breast cancer PS 13-02PS 22-05PS 22-06PS 22-07PS 23-03PS 07-06PS 24-02PS 24-07PS 24-07
breast cancer pdx PS 14-03
breast conserving surgery PS 08-02PS 03-02
bronchoscopy PS 01-05
brown fat PS 22-06
butyrycholinesteraze PS 13-05
c-direct tag PS 22-04
calcium PS 01-03
calcium epifluorescence PS 14-02
calibration PS 07-05
calu-6 PS 22-07
cancer PS 19-05PS 06-06#45PS 13-04PS 13-04PS 14-03PS 22-06PS 07-06PS 07-06PS 07-06PS 24-05PS 24-06PS 24-06PS 19-04PS 19-03
cancer imaging PS 07-02PS 24-06
cancer immunotherapy PS 07-02
cancer inflammation PS 19-05
cancer metabolism #500PS 01-03PS 02-03
cancer treatment PS 22-07
car-t PS 02-04PS 07-02
carbon-11 PS 15-06
carbon-13 PS 06-03
carbonic anhydrase ix PS 23-07
cardiac PS 07-03
cardiac arrhythmia PS 24-03
cardiac function PS 24-03#615
cardiac imaging PS 24-03PS 24-03
cardiac metabolism PS 07-03
cardiac mri PS 01-05PS 02-03
cardiac remodeling PS 01-04
cardiotoxicity PS 01-04
cardiovascular PS 07-03
cardiovascular disease PS 14-04PS 24-03
cardiovascular imaging #653
cardiovascular phenotyping PS 07-03
cartilage PS 01-02
caspase 3 PS 23-07
catecholamines PS 14-02
cathepsin PS 22-03
cavitation PS 14-05
cbf PS 14-03
ccr2 #538
cd20 PS 01-07
cd8 PS 07-02
cd8 t-lympocytes PS 07-02
cdp1 PS 24-04
ce-mri PS 08-06
cect PS 01-02
cell communication PS 02-04
cell death PS 01-01PS 13-04
cell labeling PS 23-02
cell labelling PS 24-05
cell perfusion system PS 07-04
cell therapy #91#194PS 01-03PS 13-02PS 23-05
cell tracking PS 19-05#91#86PS 01-07PS 13-03PS 22-04PS 07-02PS 07-02PS 07-02PS 24-05PS 17-02
cell-penetrating peptides PS 22-04
cells PS 19-04
cerebral blood flow PS 13-03
cerebral blood vessels PS 23-05
cerebral ischemia PS 13-03
cerebral metabolism PS 02-03
cerebral small vessel disease PS 08-06
cerebral vascular reactivity PS 13-03
cerebrospinal fluid PS 13-03
cerenkov imaging PS 08-04
cerenkov luminescence imaging PS 07-02
cest #165PS 14-02
cest mri PS 01-03PS 13-06
cest mri imaging PS 02-03
cest mri multislice sequence PS 02-03
cest mri sequence PS 02-03
cest-mri PS 24-04
cetuximab-irdye800cw PS 08-02PS 03-02
ceus PS 08-05
cgmp process PS 22-04
checkpoint blockade #561
checkpoint inhibitor therapy PS 15-05
chelate PS 24-05
chelator PS 22-04
chelators PS 23-07
chemical excahnge saturation trasnfer PS 23-02
chemical exchange saturation transfer PS 01-04
chemical shift artifacts PS 22-05
chemokine PS 24-05
chinchilla lanigerais PS 22-06
chorioallantoic membrane (cam) PS 22-05
chronic hypoperfusion PS 01-03
chronic kidney disease (ckd) PS 02-04
circulating tumor cells PS 24-07
clearance PS 08-03
click chemistry PS 23-07
clinical applications PS 14-05
clinical translation PS 16-02PS 16-03
clinical trial PS 01-06
clustering PS 23-04
co-registration PS 01-01
cognitive dysfunction PS 24-05
cognitive rehabilitation #554
collagen PS 07-06
collagen iv PS 08-06
collateralization PS 01-03
colon PS 07-06
colorectal cancer PS 18-04PS 01-06PS 08-02PS 08-02PS 08-02PS 03-02PS 03-02PS 03-02
combination therapy PS 14-03
composite phantom PS 01-06
computed tomography PS 19-06PS 07-05
connectome PS 02-05
connectomics PS 14-02PS 02-05
contrast PS 07-03
contrast agent PS 23-02PS 07-05PS 24-03PS 24-04PS 24-06PS 08-05#615
contrast agents #308PS 01-04PS 14-04PS 24-06PS 08-04#650PS 19-03
contrast recovery PS 23-03
contrast-enhanced ultrasound PS 24-02PS 24-02PS 24-07
copper-64 PS 24-02PS 24-05
crohns disease PS 08-06
cryo-electron tomography PS 05-05
cryo-em PS 14-04
ct PS 22-04PS 06-07PS 07-05PS 24-03
ctla-4 PS 02-04
cu doping PS 23-02
cuprizone PS 13-03PS 08-06
cxcr4 PS 06-07PS 23-07PS 24-05PS 24-05
cyanine dyes PS 08-02
cycling hypoxia PS 24-07
cytotoxic t cells PS 15-05
d-glucose PS 07-04
data analysis PS 02-02PS 23-04PS 19-04
data provenance PS 23-04
data referencing PS 01-06
dce-mri PS 22-05
dect PS 22-04
deep learning PS 06-06
default mode network PS 02-05
delayed type hypersensitivity reaction PS 22-03
dementia PS 17-02
denoising PS 02-02
density PS 24-04
derivatisation PS 14-02
desi PS 01-01
deuterium metabolic imaging PS 07-04
dexa PS 07-04
dfo-derivatives PS 23-07
diabetes #194PS 01-07PS 14-04
diagnosis #199
diagnostic tools PS 07-05
dicom PS 23-04
diffusion PS 06-06
diffusion approximation PS 22-06
diffusion fmri PS 17-02
diffusion imaging PS 13-06
diffusion mri PS 08-06
diffusion-weighted imaging PS 13-06
dimensionality reduction PS 23-04
direct cell labelling PS 22-04
disease model PS 07-07
dispersion correction PS 23-04
dissolution-dnp PS 02-03
dmi PS 07-04
dna damage PS 21-05#410PS 14-03
dna damage repair #427
dna repair PS 01-06
dnp #548PS 02-03
doppler PS 24-02
dota PS 06-07
dotatate #427
doxorubicin PS 08-05
dpa-714 PS 13-03
dreadd PS 02-05
drug addiction PS 23-05
drug carrier PS 24-06
drug delivery PS 01-03PS 01-07PS 02-02PS 24-06PS 03-03
drug design PS 24-06
drug discovery PS 07-05
drug distribution PS 22-07
drug evaluation PS 08-02
drug resistance PS 13-04
drug uptake #430
dss model PS 24-05
dti #568#554
dual label approach PS 17-02
dual modal PS 06-07
dual modal imaging PS 23-02
dual-frequency #308
dual-imaging PS 22-04
dual-labeling PS 22-04
dual-modal imaging PS 08-05
dual-modality PS 08-02PS 03-02
dual-pet PS 13-04
duchenne muscolar distrophy PS 06-07
duchenne muscular dystrophy PS 14-06
dwi PS 13-06PS 14-02PS 24-07
dynamic PS 01-01
dynamic contrast enhanced mri PS 13-06
dynamic nuclear polarisation PS 02-03
dynamic pet imaging PS 07-04
e-selectin PS 13-06
early detection PS 21-05PS 01-06PS 01-06
early diagnosis #500
echocardiography PS 24-03
egfr #316
egfri PS 13-06
elastography PS 24-02
electrographic seizures #520
elemental imaging PS 08-04
em PS 14-04
embryos PS 22-06
emerging clinical applications PS 19-03
endocannabionid system PS 23-05
endogeneous nad(p)h fluorescence PS 16-03
endogenous contrast PS 22-06
endomicroscopy PS 24-07
endoradiotherapy PS 24-07
endoscopic imaging PS 21-04
endoscopy PS 16-02PS 19-03
endothelin receptors PS 01-04PS 24-06
enterobacteriacea PS 24-04
epicardium-derived progenitor cells PS 22-05
epilepsy #520PS 01-03
epr effect PS 14-03PS 24-02PS 24-07
epri PS 24-07
erbb2 PS 07-06
erbb3 PS 07-06
erythropoietin PS 23-05
esophageal cancer PS 01-06
eurobioimaging #593
ex-vivo optical imaging #104
exendin PS 13-02PS 08-02
exendin-4 PS 07-04
exosomes PS 01-07PS 13-05PS 07-06
experimental autoimmune encephalomyelitis (eae) PS 23-03PS 17-02
experimental autoimmune myocarditis PS 07-03
extracellular matrix PS 01-04
extracellular matrix (ecm) PS 02-04PS 17-02
extracellular ph PS 07-04
fadu PS 13-04
fast flim #46
fast fourier transform PS 22-06
fatty acid PS 07-03
fdg pet imaging PS 23-04
fdg-pet PS 01-01PS 23-05PS 07-04
fdr PS 24-05
fenretinide (4-hpr) PS 24-05
ferritin PS 22-07
ffc-nmr PS 22-05
fibered confocal fluorescence microscopy PS 01-05
fibrils PS 23-07PS 17-02
fibroblast activation protein PS 01-04PS 13-04PS 22-03
fibronectin (fn) PS 17-02
firefly PS 24-06
fixation PS 23-03
florine mri PS 23-02
flourine-18 PS 23-07
fluence correction PS 22-06
fluorecence beads PS 08-04
fluorescence PS 16-02PS 16-02#165#104#148PS 01-06PS 14-05PS 06-07PS 22-07PS 23-02PS 08-02PS 08-02PS 24-06PS 24-06PS 24-06PS 03-02
fluorescence imaging PS 16-02PS 01-06PS 01-06PS 14-02PS 08-02PS 08-02PS 08-02PS 24-06PS 03-02PS 03-02
fluorescence lifetime imaging PS 16-03
fluorescence molecular imaging PS 01-06
fluorescence molecular tomography PS 07-02
fluorescence optical imaging PS 01-04PS 24-06
fluorescence recovery after photobleaching PS 07-06
fluorescence reflectance imaging PS 07-02
fluorescence-guided surgery PS 16-02PS 08-02PS 03-02
fluorescent PS 24-04PS 24-04
fluorescent molecular endoscopy PS 01-06
fluorescent probes PS 24-06
fluorinated nanoparticles PS 23-02
fluorine #308
fluorine-18 PS 22-04PS 23-07PS 24-05PS 08-06
fluorogenic sensor #199
fluorophores PS 16-02
fmri PS 01-03PS 14-02PS 02-05PS 07-07
folate receptor #165
four-dimensional ultrasound PS 24-03
freesurfer PS 08-06
fret #104
fret probes PS 24-06
fri PS 07-06PS 24-04
ft ir PS 23-06
ftir PS 08-06PS 19-04
functional connectivity PS 02-05PS 02-05PS 07-07
functional connectivty PS 07-07
functional diffusion PS 17-02
functional liver imaging PS 06-07
functional pet PS 02-05
functional ultrasound PS 02-05
functionalized peptides PS 06-07
fungal infection PS 01-05PS 24-04
g-quadruplex PS 22-04
ga-68 PS 23-07PS 08-04
ga68 PS 24-04
gadolium-based contrast agent PS 14-04
gallium PS 24-05
gallium-68 PS 22-04PS 06-07PS 06-07PS 23-07PS 23-07PS 08-02PS 24-05PS 03-02
gamma-delta t cells PS 07-02
gamma-h2ax PS 21-05
gbca PS 22-06
gcamp6m PS 13-02
gd chelates PS 23-02
gd_based nanoparticle PS 02-03PS 22-05
gene reporter PS 13-02PS 14-04
gene therapy PS 13-06
generic imaging agent PS 14-06
genetically engineered mouse PS 14-03
giant liposomes #165
glioblastoma PS 14-06PS 01-03PS 07-04PS 07-06PS 08-05
glioma PS 22-07PS 07-02PS 07-04PS 07-04PS 07-04PS 08-02PS 08-06PS 03-02
gliotoxin PS 08-06
global illumination PS 24-03
glutamate PS 14-02
glycolysis PS 02-03
glycosaminoglycans PS 01-02
glymphatic system PS 13-03
gold complex PS 22-07
gold nanoclusters PS 08-04
gold nanoparticle PS 01-02
gold nanorods PS 13-02PS 14-05
graph theory PS 07-07
graves’ disease PS 22-06PS 22-06
grin lenses PS 16-03
grpr PS 08-05
hcc PS 22-04
head & neck pdtx PS 13-06
head and neck cancer #534
heart PS 24-03PS 24-03
hematopoietic stem cells PS 22-03
hemoglobin PS 22-06PS 22-06
hepatocellular carcinoma PS 24-02PS 24-07
hepatocytes PS 01-07
her2 PS 23-07
high content imaging PS 07-02PS 08-04
high frequency ultrasound PS 22-06PS 24-02
high frequency ultrasound (hfus) PS 07-03PS 07-03PS 07-04
high-frequency ultrasound PS 24-07
hippocampal disinhibition PS 07-07
histology PS 19-06PS 07-05
hnis PS 01-07
hounsfield units PS 23-04
human PS 22-06PS 07-03PS 08-06
human induced pluripotent stem cells PS 01-07
human major disease PS 21-06
humanization PS 07-03
humanize mouse model PS 07-02
hungtinton PS 14-02
huntington's disease PS 13-03PS 23-05
hyaluronan PS 01-04
hybrid imaging PS 06-03
hybrid modality PS 14-02
hydrogel PS 01-03PS 14-04PS 23-05PS 07-03
hydroxytyrosol PS 23-05
hyperpolarisation PS 22-05PS 22-07
hyperpolarised mri PS 01-01
hyperpolarization PS 22-05PS 22-05PS 23-04
hyperpolarizaton PS 22-05
hyperpolarized PS 06-03
hyperpolarized 13c pyruvate PS 01-01
hyperpolarized 13c-mrs #561PS 01-01PS 07-06
hyperpolarized [1-13c]pyruvate PS 01-03
hyperpolarized mri PS 01-03
hyperpolarized pyruvate PS 02-03
hyperspectral imaging PS 24-07
hyperspectral imaging. PS 22-06
hypersynchronisation PS 07-07
hyperthermia PS 08-03
hypoxia PS 02-04PS 14-05PS 22-07PS 23-05PS 23-07PS 24-06
hypoxic fraction PS 22-07
ibd PS 07-07PS 24-05PS 24-06
icg PS 24-06
icp-ms PS 23-02
idh PS 07-04
idif PS 23-04
iedda PS 22-04
ifngamma PS 07-02
il-6 PS 01-04
image analysis PS 02-02PS 08-04#652
image correlation PS 23-04
image guided intervention PS 08-02PS 03-02
image guided surgery PS 14-06PS 24-07
image processing PS 23-04PS 23-04
image quality PS 23-03
image quantification PS 19-03
image reconstruction PS 07-05PS 19-03
image segmentation PS 23-04
image-guided surgery PS 16-02PS 01-06PS 08-02PS 08-02PS 08-02PS 03-02PS 03-02PS 03-02
image-guided tace PS 22-04
image-guided therapy PS 21-06
imaging PS 19-05PS 02-01PS 01-02PS 14-02PS 07-02PS 07-03PS 23-06PS 24-04PS 24-05PS 24-06PS 24-06
imaging biomarkers PS 19-05
imaging immune cells PS 24-06
imaging influence PS 22-05
imaging mass cytometry PS 23-06PS 23-06PS 16-07PS 16-07
imaging mass spectrometry PS 19-04PS 19-04
imc PS 14-03PS 19-04
immune challenge PS 07-02
immune checkpoint PS 07-02
immune checkpoint inhibitors PS 02-04PS 13-06
immune imaging #561
immune responses PS 19-05
immuno-oncology PS 07-02
immuno-pet PS 23-07
immunology PS 22-05
immunooncology PS 23-06PS 16-07
immunopet PS 19-05PS 15-05PS 01-05PS 23-07
immunosuppression PS 02-04
immunotherapy PS 19-05PS 19-05PS 19-05PS 13-06PS 07-02PS 07-02PS 07-02
immunotherapy tracking PS 02-04
in vivo PS 13-02PS 22-05PS 22-06PS 07-02PS 07-03
in vivo cell tracking PS 19-05PS 13-02
in vivo imaging immunotherapy PS 07-02
in vivo stability #104
indocyanine green fluorescence PS 08-02PS 03-02
inertnes PS 23-02
infection PS 01-05
infection disseases PS 01-05
infection imaging PS 24-04PS 24-04
infection probes PS 24-04
infectious diseases PS 24-04
infective endocarditis PS 01-05
inflammation PS 01-05PS 13-05PS 13-05PS 13-06PS 14-05PS 22-03PS 22-03PS 22-03PS 22-03PS 06-07PS 24-03PS 24-04
inflammatory bowel disease PS 24-06
inflammatory disease PS 19-03
infrastructure #593
input function PS 23-05
instructeric #593
instrumentation PS 16-02
insulinoma PS 13-02PS 08-02
integrating approaches PS 21-06
integrin alfa-4-beta-7 PS 24-06
integrin αvβ6 PS 23-07
interferometric scattering microscopy PS 14-02
interrater variability PS 14-02
intestine PS 24-02
intra-operative imaging PS 16-02PS 08-02PS 08-02PS 03-02
intra-operative optical imaging PS 08-02
intra-vascular imaging PS 24-03
intracellular calcium signaling PS 14-04
intraoperative diagnostics PS 23-06
intraoperative guidance PS 01-06
intraoperative imaging PS 08-02PS 08-02
intrarater variability PS 14-02
intravascular imaging PS 19-03
intravascular tumor cells PS 24-07
intravital PS 16-03
intravital 2-photon microscopy PS 13-03
intravital imaging PS 02-04PS 14-03
intravital microscopy PS 02-04PS 02-04PS 24-07
invasion PS 07-06
iodine-123 PS 14-06
irdye700dx PS 08-02PS 03-02
irfp720 PS 13-02
iron PS 22-07PS 23-05
iron biomineralization PS 14-04
iron oxide PS 08-03
iron oxide nanoparticle PS 22-03
iron oxide nanoparticles #271PS 23-02PS 23-02PS 23-02PS 08-03
iron oxide nps PS 22-05
ischemia PS 01-03PS 23-05
ischemic stroke PS 08-06
islets of langerhans transplantation PS 07-04
isoflurane PS 22-05
k-edge subtraction imaging PS 19-06PS 19-06
kidney disease PS 14-05
kinetic modeling #148#548
kinetic modelling PS 23-04
kurtosis PS 08-06
la icp ms PS 19-04
la-icp-ms PS 01-05
labelled macrophage PS 22-05
lactate PS 01-01
lactate map PS 01-01
lanthanide complex PS 23-02
laponite PS 22-04
laser ablation icp ms PS 23-06
laser spectrometry PS 08-04
leukocytes PS 07-02
life sciences PS 07-05
light attenuation PS 24-03
light-sheet microscopy PS 17-02
lipid membrane PS 14-05
lipids PS 24-03PS 16-07
lipopolysaccharides PS 22-03
liposome PS 06-07
liposome tracking PS 22-03PS 24-05PS 03-03
liposomes PS 01-07PS 23-02PS 03-03
live-cell microscopy PS 02-04
locus coeruleous PS 02-05
logan PS 02-02
long-term ultrasound PS 13-02
longitudinal mri PS 08-06
low rank approximation PS 23-04
lsfm PS 07-06PS 08-04PS 08-05
lu-177 #427PS 22-07
luciferase PS 13-02PS 24-06
luminescent metal complexes PS 22-04
lung PS 22-05PS 07-02
lung imaging PS 19-06
lung cancer #500
lung imaging PS 19-06PS 07-05
lung inflammation & fibrosis PS 07-05
lung metastasis PS 07-05
lungs administration PS 02-02
lutetium-177 PS 23-07
lymph node biopsy #148
machine learning PS 06-03PS 02-02PS 14-03PS 08-04
macrocycle PS 24-05
macrophage PS 24-03
macrophage mannose receptor PS 07-02
macrophages #567
magnesium-phthalocyanine PS 22-07
magnetic nanoparticles PS 23-02
magnetic particle imaging PS 01-02PS 08-03
magnetic resonance (mri) PS 23-05
magnetic resonance elastography (mre) PS 17-02PS 17-02
magnetic resonance imaging PS 01-04PS 01-04PS 13-03PS 14-04PS 22-05PS 07-03PS 07-07PS 08-06PS 17-02
magnetic resonance imaging (mri) PS 22-05
magnetization transfer PS 07-03
maldi PS 14-02PS 24-03PS 16-07
maldi msi PS 19-04
maldi-msi PS 07-06
malignant melanoma PS 24-02
mammalian PS 24-06
manganese biodistribution PS 23-07
manganese enhanced mri PS 23-05
manganese-52 PS 23-07PS 24-05
markov cluster algorithm PS 02-02
mass spectrometry PS 18-04PS 02-01PS 23-02PS 23-06PS 23-06PS 19-04
mass spectrometry imaging PS 23-04PS 07-04PS 23-06PS 23-06PS 23-06PS 16-07PS 16-07PS 16-07PS 19-04PS 19-04PS 19-04PS 19-04
mass spetrometry imaging PS 23-06
matrix metalloproteinases PS 14-02
matrix turnover PS 14-04
mc-38 colon carcinoma cells graft PS 22-05
mcao PS 08-06
mecp2 models PS 23-05
medical imaging physics PS 07-05
medicinal chemistry PS 13-04
melanin PS 24-06
melanoma PS 13-06
membrane biosynthesis PS 07-04
mesoporous silica nanaparticles PS 24-06
mesoscopy PS 22-06
metabolic PS 01-01
metabolic characterization PS 07-04
metabolic fingerprinting PS 07-06
metabolic imaging #561
metabolism PS 06-03PS 22-05PS 22-06PS 23-05PS 07-04PS 23-06PS 16-07
metabolite profiling PS 19-04
metabolomics PS 07-04
metabotropic glutamate receptor 5 (mglur5) 1h mr spectroscopy PS 23-03
metaspace PS 19-04
metastases PS 14-03
metastasis PS 24-02
mibg PS 08-05PS 03-03
mice PS 24-02PS 24-02PS 24-03PS 24-03PS 08-06
micro-computed tomography PS 07-05PS 24-02
microbubbles PS 01-03PS 24-06PS 24-06PS 03-03
microcapsule #194
microct PS 19-06PS 07-03PS 07-05#615
microendoscopy PS 16-03
microglia PS 13-03PS 23-05PS 08-06
microparticles of iron oxide (mpio) PS 13-06
microscopy PS 19-06PS 02-01PS 02-01#410PS 08-04PS 08-04
microstructure PS 06-06
microsystem #165
microto-mography PS 07-05
microtubule disassembly PS 14-02
minicircle PS 13-06
mis model PS 23-05
mitochondria PS 01-04
mitochondrial imaging PS 06-07
mitoxantrone PS 24-06
mixtures PS 02-02
model-based workflow PS 23-04
modelling PS 01-01
molecular fluorescence guided surgery PS 08-02PS 03-02
molecular guided surgery PS 01-06
molecular imaging PS 19-05PS 21-05PS 21-06#212PS 01-04PS 01-07PS 14-02PS 14-04PS 07-03PS 24-02PS 24-03PS 24-06PS 24-06PS 03-03
molecular imaging biomarker PS 02-04
molecular imaing PS 06-05
molecular mri PS 08-03
molecular profile PS 23-06
monitoring #199PS 07-02PS 07-02
monocytes PS 01-04PS 07-03
monomolecular probe PS 08-02
monte carlo simulation PS 23-03
morphological analysis. PS 08-04
motion correction PS 01-02
mouse PS 01-03PS 07-03PS 23-03PS 24-03PS 24-03PS 24-03PS 17-02
mouse model #568PS 13-06PS 07-07PS 24-07
mouse model of vulnerable plaque PS 07-03PS 07-03PS 07-04
mpi PS 01-02
mr PS 23-03
mr imaging PS 23-04
mri PS 06-03PS 06-06#212#308#271#554PS 01-03PS 02-02PS 02-03PS 02-03PS 13-03PS 13-03PS 14-02PS 14-04PS 14-04PS 14-04PS 14-04PS 22-05PS 22-05PS 22-05PS 22-06PS 22-07PS 23-05PS 23-05PS 23-05PS 07-03PS 07-04PS 23-02PS 23-02PS 23-02PS 23-02PS 23-02PS 23-02PS 23-03PS 24-03PS 24-03PS 24-04PS 08-03PS 08-03PS 24-07PS 24-07PS 08-06PS 08-06#631PS 03-03PS 19-04
mri anatomy PS 23-05
mri contrast agents PS 01-03PS 08-03
mri-cest PS 07-04
mri-cest images PS 02-02
mri/mrs PS 07-04
mrs PS 07-04
mrs with hyperpolarized13c-pyruvate PS 01-01
mscs #91
msi PS 14-03
msot PS 14-06PS 14-05#653
mtbi #554
multi modal imaging PS 08-02PS 03-02
multi modality PS 08-02PS 03-02
multi-modal multi-scale imaging PS 23-04
multi-omics analysis PS 07-06
multi-parametric magnetic resonance imaging (mri) PS 23-03
multi-photon PS 07-02
multiharmonic analysis PS 24-07
multimodal PS 22-04PS 23-06PS 08-03PS 16-07
multimodal imaging PS 21-06PS 02-01PS 01-05PS 13-02PS 14-03PS 23-05PS 23-06PS 08-02PS 08-03
multimodal optical imaging PS 16-03
multimodal spect/oi PS 06-07
multimodality PS 16-02PS 02-01PS 19-04
multiphoton PS 16-03
multiphoton microscopy PS 14-03
multiple animal PS 23-03
multiple sclerosis PS 01-07PS 13-03PS 13-03PS 08-06
multiple sclerosis (ms) PS 17-02
multiplex PS 13-04
multispectral optoacoustic tomography PS 14-02PS 22-06
multispectral optoacoustic tomography (msot) PS 22-06
murine PS 07-03
murine liver steatosis PS 22-05
murine oxygen saturation PS 24-03
murinised PS 24-06
myocardial infarction PS 01-04PS 01-04PS 01-04PS 22-05PS 07-03PS 07-03PS 07-03PS 24-03PS 16-07
myocardial infarcton PS 24-03
myocardial tissue engineering PS 07-03
myocarditis PS 07-03
n-acetylcysteine PS 23-05
nano carriers #410
nanobodies PS 01-07PS 22-04PS 07-02PS 08-02PS 03-02
nanobody PS 24-05
nanocrystals #212
nanoemulsions PS 24-06
nanoflowers PS 08-03
nanomedicine PS 01-02PS 13-05PS 22-04PS 06-07PS 22-07PS 24-06
nanomedicines PS 22-03PS 03-03
nanomicelles PS 23-02
nanoparticle PS 13-06PS 22-04PS 08-03PS 08-03PS 03-03
nanoparticles #86PS 01-07PS 24-03PS 08-03PS 24-06PS 24-07
nanozeolites PS 08-03
nash-hcc PS 24-02
native chemical ligation PS 22-04
near infrared PS 14-06PS 24-06
near-infrared PS 13-02
near-infrared fluorescence #653
necrosis PS 13-04
nema PS 23-03PS 23-03
neoangiogenesis PS 07-06
neobomb PS 08-05
network PS 02-02
neural networks PS 02-05
neuroimaging #308PS 01-03PS 07-07PS 08-06PS 17-02
neuroinflammation #568PS 01-03PS 13-03PS 13-03PS 13-03PS 13-03PS 23-05PS 23-05PS 08-06
neurotensin PS 08-02PS 03-02
neurovascular coupling PS 07-07
neutrophil PS 02-04
neutrophils PS 22-03PS 17-02
new chemical probes for mri PS 14-04
nf-κb PS 01-05
nis PS 02-04PS 14-03
nk cell PS 02-04
nmr PS 22-05PS 07-04
nociception PS 07-07
nodaga PS 06-07
noise reduction PS 23-04
non-human primates PS 24-04
non-invasive imaging #199
non-linear multimodal imaging PS 08-04
non-local means filter PS 02-02
non-persistent radical PS 02-03
nonhuman primate PS 24-04
nonlinear optical microscopy PS 16-03
noradrenaline PS 02-05
nota PS 06-07
novel radiochemistry PS 15-06
nuclear imaging PS 06-07PS 24-03
nuclear magnetic spectroscopy PS 23-04
nuclear medicine PS 24-05
nuclear microprobes PS 07-05
oeosphageal cancer PS 21-04
omega-k migration PS 22-06
omics PS 02-01
oncogene-induced senescence PS 07-04
oncology PS 16-02PS 02-01#538PS 08-05PS 03-03
opiates PS 23-05
optical PS 24-06
optical coherence tomography PS 16-03PS 24-03
optical imaging PS 14-06PS 01-03PS 01-05PS 01-06PS 22-03PS 22-04PS 22-07PS 22-07PS 07-02PS 07-02PS 07-03PS 08-02PS 24-04PS 24-04PS 24-06PS 24-06PS 08-04PS 24-07PS 08-05PS 03-02PS 19-03
optical molecular imaging. PS 24-04
optical projection tomography #148
optical transfer function PS 22-06
optics PS 02-01
opto-rtk PS 13-02
optoacoustic PS 14-06#567PS 13-04PS 14-05PS 22-06PS 22-06PS 22-06PS 24-03PS 24-06
optoacoustic imaging PS 13-02PS 13-02PS 14-02PS 14-02PS 14-03PS 14-05PS 24-06PS 24-07PS 19-03PS 19-03
optoacoustic mesoscopy PS 19-03
optoacoustic tomography PS 19-03
optoacoustics PS 19-03
optofmri PS 07-07
optogenetics PS 02-05PS 07-07PS 24-03
optokinases PS 13-02
organic chemistry PS 23-02
organic synthesis PS 23-02
oscillating gradients PS 24-07
osteomyelitis PS 24-04
ovarian cancer PS 08-02
oxidative stress PS 13-05PS 06-07
oxygen enhanced imaging PS 24-07
oxygen imaging PS 24-07
oxygen saturation PS 22-06
oxygenation PS 16-02PS 13-04PS 14-05PS 22-06PS 22-06
oxygenation-sensitive mri PS 22-05
p-glycoprotein PS 02-02
p2x7r PS 13-03
p301s PS 06-07
p53 PS 21-05
pa-peg nanoparticles PS 08-05
pai PS 23-02
pan cancer PS 07-06
pancreas PS 14-04
pancreatic cancer PS 16-02PS 21-05#316PS 02-02PS 14-03PS 08-04
pancreatic ductal adenocarcinoma PS 01-01PS 13-04PS 13-06
pancreatic islets PS 01-07
para-hydrogen PS 22-05
paramagnetic complexes PS 23-02
parp PS 21-05
parp1 PS 01-06
passive elastography PS 14-05
pathology PS 19-04
patient stratification PS 14-03
patients PS 08-02PS 03-02
pd PS 07-02
pd-l1 PS 02-04
pdac PS 21-05
pdt PS 08-03
pediatric imaging PS 14-06
pentixafor PS 06-07
peptide PS 23-07
peptide targeting PS 14-04
peptides PS 21-05
perfecta micelles PS 08-03
perfluorocarbon PS 08-03
perfluorocarbons PS 13-02PS 22-03
perfusion PS 14-05#650
peritoneal carcinomatosis PS 01-06PS 08-02
personalised medicine PS 22-03PS 03-03
pertechnetate PS 01-07
pertussis PS 01-05
pet PS 21-05#91PS 01-03PS 01-04PS 01-07PS 01-01PS 02-02PS 02-02PS 02-04PS 13-04PS 13-04PS 13-04PS 13-05PS 13-05PS 13-05PS 13-05PS 13-03PS 14-03PS 22-03PS 22-04PS 22-04PS 06-07PS 06-07PS 06-07PS 06-07PS 22-07PS 07-02PS 23-05PS 07-03PS 23-04PS 23-04PS 07-04PS 07-04PS 07-04PS 23-07PS 23-03PS 23-03PS 24-02PS 08-02PS 08-02PS 24-04PS 08-03PS 24-05PS 24-05PS 24-05PS 08-05PS 08-05PS 08-06PS 08-06PS 03-03PS 03-03
pet image PS 24-05
pet imaging #316#538PS 13-03PS 22-04PS 22-04PS 23-07PS 23-07PS 23-07PS 24-03
pet metallomics PS 23-07
pet probe PS 01-01
pet tracer #45PS 23-07PS 24-05
pet-ct PS 02-02PS 06-07PS 23-04PS 24-04PS 24-04
pet-ct imaging PS 23-04
pet-tracers PS 08-03
pet/ct PS 02-02PS 23-03
pet/ct imaging #534PS 13-05
pet/ct infection imaging PS 24-04
pet/mri #86PS 01-02PS 22-03PS 22-05PS 23-03
petmr PS 23-03PS 17-02
pfcs PS 22-03PS 22-03
pfkfb3 enzyme PS 13-05
ph imaging PS 24-04
ph probe PS 13-02
phage-display PS 22-05
pharmacokinetics PS 13-05PS 07-02PS 23-06
phase contrast imaging PS 19-06
phlip PS 13-02
phosphines PS 24-05
photo-cidnp PS 22-05
photoacoustic PS 16-02PS 02-01PS 22-06PS 07-03PS 24-03PS 24-06PS 24-06PS 24-06
photoacoustic imaging PS 16-03PS 14-02PS 14-05PS 22-07PS 24-06PS 19-03
photoacoustic tomography PS 18-05PS 22-06PS 17-02
photoacoustics PS 13-02PS 22-06PS 22-06PS 19-03PS 19-03
photodynamic therapy PS 13-02PS 13-04PS 22-03PS 22-07PS 08-02PS 08-05PS 03-02
photoimmunotherapy PS 08-02PS 03-02
photopharmacology PS 24-04
photostimulation PS 24-03
phthalocyanine PS 22-07
physical exercise PS 23-05
picolinate PS 24-05
plaque characterization PS 07-03
plasma pk PS 23-05
plga nanoparticles #104PS 24-05
pml PS 07-06
pneumonia PS 24-04
positron emission PS 01-02
positron emission tomography PS 01-05PS 07-03PS 24-03PS 08-02PS 03-02#652
positron emission tomography (pet) PS 23-05
positron emssion tomography (pet) PS 23-03
power doppler PS 22-06
pre-metastatic niche PS 07-02
precision image-guided small animal radiotherapy PS 08-05
preclinical #316#554PS 02-02
preclinical evaluation PS 22-04
preclinical imaging PS 01-07PS 23-04
preclinical pet PS 01-02
pregnancy PS 22-06
premetastatic niche PS 07-06
pretargeting PS 01-02PS 06-07PS 24-03
primary cell cultures PS 08-05
probes PS 24-06
probes development PS 15-06
prostaglandins PS 23-06PS 16-07
prostate cancer PS 01-06PS 13-06PS 22-04PS 06-07PS 22-07PS 08-05
prostate cancer. PS 23-04
protease PS 22-03
protein synthesis PS 23-05
protein tau PS 06-07
proton mri PS 23-02
prrt #427
pseudomonas aeruginosa PS 24-04
psma PS 01-06PS 22-07PS 23-07PS 07-06
psma pet/ct PS 23-04
pulmonary fibrosis PS 07-05
purple bacteria #567
pve PS 23-04
pyruvate PS 06-03PS 02-03PS 22-05
quality control PS 07-05
quantification PS 22-06PS 07-02PS 23-04PS 23-04#652
quantitative #631
quantitative image analysis PS 23-04
quantitative mri PS 24-04
quantitative mri/spect PS 08-03
quantitative optical imaging PS 01-06
quantitative photoacoustics PS 22-06
quorum sensing PS 24-04
radiobiology PS 07-02
radiochemistry PS 23-07
radiofluorination PS 22-04
radiolabeling #86
radiolabelling PS 01-07PS 13-05
radiolabling PS 08-03
radiology PS 21-06
radiomics PS 02-02PS 23-04
radionucleide PS 08-05
radiopharmaceutical PS 01-07PS 24-02
radiosafety PS 07-05
radiosensitizer PS 02-03
radiotherapy PS 13-04PS 07-02
raman PS 16-02
raman imaging #430
rats PS 02-05PS 07-07
real-time surgical guidance PS 01-06
receptor tyrosine kinases PS 07-06
reconstruction PS 13-04
red-shifted PS 24-06
redox-responsive probe PS 14-04
regenerative medicine PS 14-04
registration PS 08-04
regulatory t cells PS 02-04
relaxation PS 23-02
renal clearance PS 08-05
renal fibrosis PS 02-04
reporter gene PS 07-02
reporter gene imaging PS 19-05
reproducibility PS 14-02
research workflow PS 23-04
resection PS 16-02
resection margins PS 08-02PS 03-02
respiratory PS 23-06
response assessment PS 19-05
response to therapy PS 13-04
responsive probes PS 23-02PS 03-03
resting state PS 07-07
resting state functional mri PS 02-05
resting-state fmri PS 02-05PS 07-07
retrospective reconstruction PS 02-03
rett syndrome PS 23-05
rgd #534
rhenium PS 24-05
rheumatoid arthritis #199PS 22-03PS 22-03PS 03-03
rheumatoid arthrits PS 01-01
riboflavin PS 22-05
rm2 PS 08-05
rna-ish PS 23-06PS 16-07
ros PS 01-05PS 13-05
rs6971 genetic polymorphism PS 13-05
ryrs stabilizers PS 06-07
s aureus PS 01-05
s. aureus PS 01-05PS 24-04
s100a9 PS 07-02
sa-ß-gal #45
sabre PS 22-05
safety PS 23-02
sar PS 24-05
scandium 44 PS 23-07
scintigraphy PS 08-05
self-gated PS 23-03PS 24-03
semiquantitative assessment PS 23-04
senescence #45PS 07-04PS 07-06
sensory stimulation PS 17-02
sepsis PS 24-04PS 08-04
serotonin transporter PS 02-05
sert PS 02-05
severity PS 07-07
sgm-101 PS 08-02PS 03-02
shg PS 07-06
shock wave PS 14-05
short-chain acyl-coenzyme a synthetase PS 01-01
siderophores PS 24-04
simplified PS 23-04
sims PS 14-02
simultaneous pet/ct-uui system PS 01-02
simultaneous pet/fmri PS 07-07
simultaneous pet/mri PS 02-05
single cell tracking PS 22-03
single molecule fluorescence microscopy PS 07-06
single molecule localisation microscopy #588
single particle tracking PS 14-02
single photon emission computed tomography #652
single-cell PS 19-04
single-chain variable fragment PS 07-03
single-chain variable fragments PS 23-07
site-directional conjugation PS 22-04
site-specific PS 22-04
skin PS 07-05
slc6a4 PS 02-05
sleep scoring PS 02-05
slow wave state PS 14-02
small animal PS 23-03PS 17-02PS 17-02
small animal research PS 23-04
small molecule radiotracer #538
small-scale PS 22-07
solid immersion lens #588
solid phase peptide synthesis PS 22-04
sonophore PS 13-02
sonophores PS 24-06
sorbitol PS 24-04
spad array #46
spatial metabolomics PS 19-04PS 19-04
spect PS 14-06PS 01-04PS 01-07PS 01-07PS 01-07PS 01-07PS 14-03PS 22-04PS 07-02PS 07-03PS 07-05PS 24-03PS 24-03
spect-imaging PS 07-07
spect/ct PS 01-07PS 24-05
spect/ct imaging PS 02-04PS 23-07
spectrometer PS 14-05PS 22-06
spectroscopy PS 19-03
spill-in effect PS 23-04
spim PS 08-04
spin-echo PS 22-05
spinal cord PS 08-06
spleen PS 24-02
srs microscopy #430
stability PS 23-02
standardisation PS 07-04
standardised uptake value (suv) PS 23-04
standardization PS 16-02PS 16-02PS 01-06PS 02-02PS 23-04
standarised uptake value PS 23-04
star polymer PS 24-07
statistical analysis PS 23-04
stem cell delivery PS 14-05
stem cells #91
stress level assessment PS 22-05
stroke #548PS 13-03PS 23-05PS 23-05PS 23-05PS 23-03PS 08-06
subcutaneous cancer xenograft model PS 14-02
suicide gene system PS 13-06
suicide gene therapy PS 22-07
super resolution in cardiac pet PS 01-02
super-resolution #588
supramolecular PS 01-07
surgery PS 08-02
surgical resection PS 16-02
sv2a #520
swir imaging PS 08-04
synaptic density #520
synchrotron PS 23-03PS 08-06
synchrotron imaging PS 19-06
synchrotron radiation PS 19-06
synchrotrons PS 19-06
synthesis PS 14-04PS 23-07
synucleinopathies PS 23-07
systemic inflammation PS 23-05
t cell bi-specific PS 07-02
t-cell therapy PS 07-02
t1-weighted mri PS 23-02
targeted imaging agents PS 16-02
targeted therapy PS 08-02PS 03-02
tau tracer PS 23-05
tc(i) PS 06-07
tcspc #46
technetium-99 PS 24-05
technetium-99m PS 01-07PS 24-05
temozolomide PS 08-05
tendon PS 22-06
tet-off app mouse model PS 07-07
tetrazine PS 22-04
texture analysis PS 23-04
texture-analysis PS 23-04
tg6799 PS 13-05
thanostic PS 24-06
thc PS 23-05
theranostic PS 08-03PS 24-06PS 08-05
theranostic nanoparticle PS 02-03PS 22-05
theranostic nanoparticles PS 22-07
theranostics PS 14-06PS 13-06PS 22-04PS 22-07PS 23-02PS 24-06PS 24-07PS 03-03PS 03-03
therapeutic biomarkers PS 24-05
therapy-response PS 07-02
thermoresponsive probes PS 23-02
thp PS 06-07
thrombolysis PS 03-03
thyroid PS 24-02
thyroid nodule PS 22-06
time-intensity curves PS 24-07
time-lapse mri PS 22-03
time-resolved PS 07-05
tissue analysis PS 23-06PS 16-07
tissue clearing PS 17-02
tissue engineering PS 01-07
tissue heterogeneity PS 23-04
tissue imaging PS 07-05PS 19-04
tissue sections PS 19-04
tissue-engineering PS 01-02
tissue-transparency window PS 13-02
titanocene PS 08-05
tlr2 PS 08-06
tnbc PS 02-04
tof-sims PS 24-03PS 16-07
told PS 22-05
tomograph PS 01-02
total body pet PS 23-03
total-body PS 01-02
traceability PS 23-04
tracer PS 01-05PS 07-03
tracer development PS 07-02PS 24-06
tracer kinetic modeling PS 23-04
tracer-based imaging PS 01-02
tracking PS 01-07
translation PS 06-05
transplantation PS 02-04
trastuzumab PS 23-07
traumatology PS 24-04
traveling waves PS 14-02
treatement PS 01-03
treatment PS 01-05
treatment response PS 01-01PS 14-03
tricarbonyl PS 24-05
tropoelastin PS 14-04PS 14-04
tspo PS 01-03PS 13-04PS 13-05PS 13-03PS 23-04
tuberculosis PS 24-04
tumor PS 14-02PS 07-06PS 24-02
tumor heterogeneity PS 24-07
tumor immunology PS 07-02
tumor limited perfusion PS 24-07
tumor margin assessment PS 23-06
tumor matabolism PS 01-01
tumor microenvironment PS 22-07PS 07-02
tumor models PS 22-06
tumor oxygen saturation PS 24-07
tumor spheroids PS 24-07
tumor targeting PS 07-02
tumor vascularization PS 23-04
tumor-associated macrophages PS 07-02
tumour PS 14-05
tumour biology PS 07-06
tumour heterogeneity PS 07-04
tumour imaging PS 01-01
tumour metabolism PS 07-04
tumour oxygenation PS 19-03
tumour targeting PS 22-04PS 24-02
tumour-activatable PS 13-06
two-photon excitation PS 16-03
two-photon microscopy PS 24-07
type 1 diabetes (t1d) PS 07-04
u87mg PS 07-06
ultra-small size PS 08-05
ultrafast imaging #650
ultrafast ultrasound imaging PS 14-05
ultrasound PS 01-03PS 22-06PS 22-06PS 07-03PS 07-03PS 24-02PS 24-02PS 24-03PS 24-06PS 08-05#650PS 19-03
ultrasound guided injection PS 14-05
ultrasound imaging PS 24-06PS 03-03
unmixing PS 14-05PS 22-06
uspio labeling PS 07-02
uterine tissue PS 23-06PS 16-07
vacht PS 24-05
validation PS 19-05PS 22-04
variable domains of camelid heavy chain-only antibodies (vhh) PS 22-04
vascular calcification PS 01-04
vascular disease PS 19-03
vascular dysfunction PS 22-05
vascular imaging PS 03-03
vascular microenvironment PS 14-03
vasculature PS 13-04PS 14-03PS 22-03
vhh PS 23-07
virtual histology PS 19-06PS 23-04
visual stimulation PS 02-05
visualization PS 23-04
volumetry PS 23-03
voxel-by-voxel analysis PS 02-02
vulnerable plaque #271
watersoluble fluorophores PS 24-06
whole-cell sensor PS 13-02
whooping cough PS 01-05
williams-beuren PS 07-03
x-ray contrast agents PS 24-02
x-ray imaging PS 19-06
x-ray phase contrast imaging PS 19-06
x-ray phase contrast tomography PS 23-04
xnat PS 23-04
xray PS 19-06
xrf PS 19-04
zebrafish PS 02-03PS 23-03
zinc PS 06-07
zirconium-89 PS 22-04
zr-89 PS 07-02
µxrf PS 23-06
α-synuclein PS 07-07
α7 nachr PS 08-06
μct PS 07-05